http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
3D Asthenopia in Horizontal Deviation
Kim, Seung-Hyun,Suh, Young-Woo,Yun, Cheol-Min,Yoo, Eun-Joo,Yeom, Ji-Hyun,Cho, Yoonae A. Informa Healthcare USA, Inc. 2013 Current eye research Vol.38 No.5
<P><I>Purpose:</I> This study was conducted to investigate the asthenopic symptoms in patients with exotropia and esotropia while watching stereoscopic 3D (S3D) television (TV).</P><P><I>Methods:</I> A total 77 subjects who more than 9 years of age were enrolled in this study. We divided them into three groups; Thirty-four patients with exodeviation (Exo group), 11 patients with esodeviation (Eso group) and 32 volunteers with normal binocular vision (control group). The S3D images were shown to all patients with S3D high-definition TV for a period of 20 min. Best corrected visual acuity, refractive errors, angle of strabismus, stereopsis test and history of strabismus surgery, were evaluated. After watching S3D TV for 20 min, a survey of subjective symptoms was conducted with a questionnaire to evaluate the degree of S3D perception and asthenopic symptoms such as headache, dizziness and ocular fatigue while watching 3D TV.</P><P><I>Results:</I> The mean amounts of deviation in the Exo group and Eso group were 11.2 PD and 7.73PD, respectively. Mean stereoacuity was 102.7 arc sec in the the Exo group and 1389.1 arc sec in the Eso group. In the control group, it was 41.9 arc sec. Twenty-nine patients in the Exo group showed excellent stereopsis (≤60 arc sec at near), but all 11 subjects of the Eso group showed 140 arc sec or worse and showed more decreased 3D perception than the Exo and the control group (<I>p</I> < 0.001, Kruskal-Wallis test). The Exo group reported more eye fatigue (<I>p</I> < 0.001, Kruskal-Wallis test) than the Eso and the control group. However, the scores of ocular fatigue in the patients who had undergone corrective surgery were less than in the patients who had not in the Exo group (<I>p</I> < 0.001, Kruskal-Wallis test) and the amount of exodeviation was not correlated with the asthenopic symptoms (dizziness, <I>r</I> = 0.034, <I>p</I> = 0.33; headache, <I>r</I> = 0.320, <I>p</I> = 0.119; eye fatigue, <I>r</I> = 0.135, <I>p</I> = 0.519, Spearman rank correlation test, respectively).</P><P><I>Conclusion:</I> Symptoms of 3D asthenopia were related to the presence of exodeviation but not to esodeviation. This may indicate that S3D symptoms are closely related to the convergence demand.</P>
Layer-controlled thinning of black phosphorus by an Ar ion beam
Park, Jin Woo,Jang, Sung Kyu,Kang, Dong Ho,Kim, Doo San,Jeon, Min Hwan,Lee, Won Oh,Kim, Ki Seok,Lee, Sung Joo,Park, Jin-Hong,Kim, Kyong Nam,Yeom, Geun Young Royal Society of Chemistry 2017 Journal of Materials Chemistry C Vol.5 No.41
<▼1><P>BP thinning was carried out using a monoenergetic Ar<SUP>+</SUP> ion beam and the BP could be thinned without damaging the surface.</P></▼1><▼2><P>Black phosphorus (BP) is one of the most interesting two-dimensional (2D) layered materials due to its unique properties, including a band gap energy change from 0.3 eV (bulk) to 2.0 eV (monolayer) depending on the number of BP layers, for application in nanoelectronic devices. In general, 2D layered materials including BP have limitations in terms of synthesis due to the process factors such as time, temperature, <I>etc.</I>, and thus, a thinning technique from the bulk material to a 2D material needs to be used while controlling the removed layer thickness. In this study, layer-controlled thinning of BP was performed by using a controlled Ar<SUP>+</SUP> ion beam method and the BP thinning characteristics were investigated. By using the near monoenergetic ion energy in the range of 45–48 eV, BP could be thinned with the thinning rate of ∼0.55 nm min<SUP>−1</SUP> down to bilayer BP without increasing the surface roughness and without changing the chemical binding states. The BP oxide on the pristine BP could also be successfully removed using the same Ar<SUP>+</SUP> ion beam. 2D BP field-effect transistors (FETs) fabricated with the thinned bilayer–10-layer BPs exhibited electrical characteristics similar to those of pristine BP FETs suggesting no electrical damage on the BP layers thinned by the controlled monoenergetic Ar<SUP>+</SUP> ion beam.</P></▼2>
Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
Kang, Min Ah,Kim, Jong-Tae,Kim, Joo Heon,Kim, Soo-Young,Kim, Young Ho,Yeom, Young Il,Lee, Younghee,Lee, Hee Gu Springer-Verlag 2009 Journal of cancer research and clinical oncology Vol.135 No.6
<P>CKS2 was identified as an upregulated gene in gastric cancer via our DNA microarray. This study was to verify the upregulation of CKS2 in many gastric cancer patients and to examine the CKS2-mediated cellular response.</P>
Kang, Min Hyung,Yoo, Hyun Joon,Kwon, Yie Hyuk,Yoon, Ho Yub,Lee, Sang Gon,Kim, Sung Rae,Yeom, Dong Woo,Kang, Myung Joo,Choi, Young Wook American Chemical Society 2015 MOLECULAR PHARMACEUTICS Vol.12 No.12
<P>As a novel carrier for folate receptor (FR)-targeted intracellular delivery, we designed two types of targetable liposomal systems using Pep-1 peptide (Pep1) and folic acid as a cell-penetrating peptide (CPP) and target molecule, respectively. Folate-linked Pep1 (Fol-Pep1) was synthesized by solid phase peptide synthesis (SPPS) and verified using <SUP>1</SUP>H NMR and far-ultraviolet (UV) circular dichroism (CD). The chimeric ligand (Fol-Pep1)-modified liposome (cF-P-L) was prepared by coupling Fol-Pep1 to maleimide-derivatized liposomes at various ratios. The dual ligand (folate and Pep1)-modified liposome (dF/P-L) was prepared by separately attaching both ligands to the liposomal surface via a short (PEG<SUB>2000</SUB>) or long (PEG<SUB>3400</SUB>) linker. The physical and conformational characteristics including vesicle size, zeta potential, and the number of conjugated ligands were determined. Intracellular uptake specificities of various fluorescent probe-containing cF-P-L and dF/P-L systems were assessed using FR-positive HeLa and FR-negative HaCaT cells. Cellular uptake behavior was visualized by confocal laser scanning microscopy (CLSM). Internalization was time-dependent. Fol-Pep1 and Pep-1 cytotoxicities were negligible up to 25 μM in FR-positive and FR-negative cells. Empty cF-P-L and dF/P-L were nontoxic at the concentration used. The optimized dF<SUB>3</SUB>/P<SUB>2</SUB>(450/90) system carrying 450 PEG<SUB>3400</SUB>-linked folate and 90 PEG<SUB>2000</SUB>-linked Pep1 molecules could be a good candidate for FR-specific intracellular drug delivery.</P><P><B>Graphic Abstract</B> <IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/mpohbp/2015/mpohbp.2015.12.issue-12/acs.molpharmaceut.5b00399/production/images/medium/mp-2015-00399k_0010.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/mp5b00399'>ACS Electronic Supporting Info</A></P>